Pfizer to seek OK for 3rd vaccine dose

Sharing is Caring!

Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.

Research from multiple countries shows the Pfizer shot and other widely used COVID-19 vaccines offer strong protection against the highly contagious delta variant, which is spreading rapidly around the world and now accounts for most new U.S. infections.

Two doses of most vaccines are critical to develop high levels of virus-fighting antibodies against all versions of the coronavirus, not just the delta variant — and most of the world still is desperate to get those initial protective doses as the pandemic continues to rage.

See also  Pfizer CEO pulls out of testifying to EU Parliament COVID panel

apnews.com/article/europe-coronavirus-pandemic-science-health-34c3f2536747a7c08980d7359a8de70c

Trending:
See also  Pfizer asks FDA for "emergency use" authorization of its upgraded Omicron mRNA injections in children 5 to 11 years old.

Views: 2

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.